Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: West J Nurs Res. 2019 Jan 7;41(11):1602–1622. doi: 10.1177/0193945918820672

Table 4.

Differences in blood sex hormones at each time point between intervention and control groups (N = 13).

Blood Sex Baseline (M ± SD) 6 months (M ± SD) 9 months (M ± SD)
Hormones DEEM Control pa,c DEEM Control pb,c DEEM Control pb,c

Serum E1, pg/ml 21.5 ± 6.6 40.4±14.2 .439 19.2 ± 1.9 40.7 ± 14.8 .439 18.9 ± 1.6 40.4 ± 24.5 .048
Serum E2, pg/ml 6.3 ± 3.3 24.2±17.2 .137 12.9 ± 12.8 38.7 ± 31.2 .143 3.1 ± 4.7 26.2 ± 51.3 .039
A-dione, ng/ml 0.51 ± 0.1 0.5 ± 0.2 .751 0.6 ± 0.3 0.5 ± 0.1 .775 0.4 ± 0.1 0.5 ± 0.1 .475
DHEA, ng/ml 2.6 ± 0.4 3.5 ± 1.8 .253 3.1 ± 1.3 3.1 ± 0.7 .668 2.1 ± 0.2 3.0 ± 0.7 .063
T, ng/ml 0.2 ± 0.1 0.2 ± 0.1 .775 0.2 ± 0.1 0.2 ± 0.1 .520 0.2 ± 0.1 0.2 ± 0.1 .999
SHBG, nM 173.1 ± 13.3 162.3 ± 9.7 .775 164.4 ± 13.9 174.7 ± 9.9 .568 160.0 ± 10.6 136.6 ± 7.2 .886

Note. M = mean; SD = standard deviation.

A-dione = androstenedione; DHEA = dehydroepiandrosterone; E1 = estrone; E2 = estradiol; SHBG = sex-hormone binding globulin;

T = testosterone.

a

Testing the differences of baseline between DEEM intervention and control groups.

b

Testing the differences in blood sex hormones at each time point (6 months and 9 months) between DEEM and control groups, controlling for baseline outcome variables.

c

p < 0.05, p-values were determined with rank-transformation using a Kruskal-Wallis test.